Palladium-Item
View Comments
RICHMOND, Ind. Earlham College raised $1.3 million from 2,949 donors at its seventh annual Earlham Day, shattering the previous record of the day-of-giving event, according to a release.
“I am truly blown away by not only the generosity of our worldwide community, but also the deep commitment demonstrated by our alumni and friends at a time of great uncertainty in our world,” Earlham President Anne Houtman said. “This year’s Earlham Day has strengthened our capacity to support future generations of students who will go on to become the kind of change-makers the world so desperately needs.”
The record-setting event was fueled by the generosity of a group of alumni and other benefactors who matched every donor’s gift, of all amounts, by $200, despite the event being held virtually due to the ongoing COVID-19 pandemic.
Containing 95% Less Nicotine than Traditional Cigarettes, VLN
® is the Only Combustible Tobacco Product that Complies with the FDA’s Proposed Nicotine Cap
/EIN News/ WILLIAMSVILLE, N.Y., April 01, 2021 (GLOBE NEWSWIRE) 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that it continues to be confident on the renewal of the FDA’s proposed reduced nicotine mandate that would make all cigarettes “minimally or non-addictive.” By way of support, four former U.S. Food and Drug Administration (FDA) commissioners, Robert M. Califf, M.D. MACC; Scott Gottlieb, M.D.; Peggy Hamburg, M.D.; and, Jane Henney, M.D., spoke on a recent panel and were vocal in their endorsement of the mandate to limit the amount of nicotine in cigarettes to levels already achieved by 22nd Century’s reduced nicotine content cigarettes, VLN
POLITICO
Get the Prescription Pulse newsletter
Email
Sign Up
By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Presented by Coalition for Affordable Prescription Drugs
With Brianna Ehley and Emily Martin.
On Tap Novavax touts the effectiveness of its Covid-19 vaccine. FDA scrutinizes its accelerated drug approval program.
It’s Tuesday, welcome back to Prescription Pulse. Turns out Transportation Secretary Pete Buttigieg is competing with the rest of us for D.C.’s scarce bicycle stock. As always, send tips to Sarah Owermohle ([email protected] or @owermohle) and David Lim ([email protected] or @davidalim).
Mar 11, 2021 12:08pm
Who will lead the FDA under President Joe Biden? Former FDA chiefs are urging Biden to hurry up and make a choice. (FDA)
The clock is ticking on an FDA commissioner nomination, with public pressure on President Joe Biden to pick up the pace.
Six former FDA commissioners wrote the White House this week urging Biden to make a choice, according to several media reports.
The letter, signed by Robert Califf, Scott Gottlieb, Margaret Hamburg, Jane Henney, Mark McClellan and Andrew von Eschenbach, pushed Biden to act in the face of the ongoing coronavirus pandemic. They noted vaccine, drug and testing issues related to the pandemic, as well as the need to implement new tobacco regulations, according to The Washington Post.